-
Mashup Score: 12
During the International Myeloma Society 5th Immune Effector Cell Workshop, the Multiple Myeloma Hub was pleased to speak to Irene Ghobrial, Dana-Farber Cancer Institute, Boston, US. We asked, What is the rationale for T-cell therapies in the treatment of smoldering MM?
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis - 9 day(s) ago
Abstract. Bispecific antibodies, a novel immunotherapy with promising efficacy against multiple myeloma, form immune synapses between T-cell surface marker CD3
Source: ashpublications.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Symposium | Q&A session - 10 day(s) ago
The Multiple Myeloma Hub virtual symposium held on March 11, 2024 entitled “Current and future perspectives for bispecific antibodies in multiple myeloma: Le…
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Antigen escape as a mechanism of resistance to T-cell-engaging therapies in multiple myeloma - 11 day(s) ago
Here, we summarize a presentation by Paola Neri on the mechanisms of antigen escape after T-cell-redirecting therapies, presented at the 5th Immune Effector Cell Therapies in Multiple Myeloma Workshop.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy? - 15 day(s) ago
The Multiple Myeloma Hub and Lymphoma Hub were pleased to speak to Anna Sureda, Catalan Institute of Oncology, Barcelona, ES. We asked, What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy?
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Sequence not salvage - 1 month(s) ago
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Podcasts | The Hematologist | American Society of Hematology - 1 month(s) ago
Podcasts | The Hematologist | American Society of Hematology Podcasts The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights from published articles in a convenient audio format. All of the podcasts are available for FREE! Learn more. Where to Listen Listen to the podcasts below (Internet connection required) or download and listen to…
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Here, we summarize a study published by Nieto et al. in American Journal of Hematology on the safety and efficacy of high-dose panobinostat combined with GemBuMel therapy following ASCT salvage in RRMM or high-risk MM.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4DREAMM-2: Long-term analysis of efficacy and safety of belamaf in patients with RRMM - 5 month(s) ago
Here, we summarize the key findings of a long-term analysis of the DREAMM-2 trial evaluating the efficacy and safety of belamaf in patients with relapsed/refractory multiple myeloma.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2MajesTEC-1: Incidence and management of infections in patients with RRMM treated with teclistamab - 5 month(s) ago
Here, we summarize key findings from the MajesTEC-1 study on the incidence, timing, and management of infections occurring in patients with RRMM treated with teclistamab.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
🎥 The Multiple Myeloma Hub was pleased to speak to @IrenemGhobrial, @DanaFarber, Boston, US. We asked, What is the rationale for T-cell therapies in the treatment of smoldering MM? Watch here: https://t.co/UySmWQiIhd #mmsm #myeloma https://t.co/dLHu21xkFy